FLCNX
Price
$37.33
Change
-$0.06 (-0.16%)
Updated
Dec 3 closing price
Net Assets
36.98B
VIGRX
Price
$253.05
Change
+$0.01 (+0.00%)
Updated
Dec 3 closing price
Net Assets
357.2B
Interact to see
Advertisement

FLCNX vs VIGRX

Header iconFLCNX vs VIGRX Comparison
Open Charts FLCNX vs VIGRXBanner chart's image
Fidelity Contrafund K6
Price$37.33
Change-$0.06 (-0.16%)
VolumeN/A
Net Assets36.98B
Vanguard Growth Index Investor
Price$253.05
Change+$0.01 (+0.00%)
VolumeN/A
Net Assets357.2B
FLCNX vs VIGRX Comparison Chart in %
View a ticker or compare two or three
VS
FLCNX vs. VIGRX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FLCNX is a Buy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 357B vs. FLCNX (37B). VIGRX pays higher dividends than FLCNX: VIGRX (0.30) vs FLCNX (0.23). FLCNX was incepted earlier than VIGRX: FLCNX (9 years) vs VIGRX (33 years). FLCNX (0.45) is less costly to investors than VIGRX (0.17). FLCNX is a more actively managed with annual turnover of: 19.00 vs. VIGRX (11.00). FLCNX has a lower initial minimum investment than VIGRX: FLCNX (0) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 18.49 vs. FLCNX (17.04). FLCNX return over 5 years is better than : 105.18 vs. VIGRX (99.11).
FLCNXVIGRXFLCNX / VIGRX
Total Expense Ratio0.450.17265%
Annual Report Gross Expense Ratio0.450.17265%
Fund Existence9 years33 years-
Gain YTD20.07119.764102%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets37B357B10%
Annual Yield % from dividends0.230.3074%
Returns for 1 year17.0418.4992%
Returns for 3 years111.65110.82101%
Returns for 5 years105.1899.11106%
Returns for 10 yearsN/A349.13-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK30.961.15
+3.86%
Stoke Therapeutics
NEPH5.400.09
+1.69%
Nephros
TACO10.15N/A
N/A
Berto Acquisition Corp
HVIIU10.60N/A
N/A
Hennessy Capital Investmnt Corp VII
AHR50.31-0.13
-0.26%
American Healthcare REIT